Berg-Candolfi M and Candolfi E |
Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection. |
1996 |
Int. J. Parasitol. |
pmid:9024879
|
Griffith DE et al. |
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease. |
1996 |
Clin. Infect. Dis. |
pmid:8953085
|
Wallace RJ et al. |
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. |
1996 |
Am. J. Respir. Crit. Care Med. |
pmid:8665032
|
Frothingham R |
Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease. |
1996 |
Am. J. Respir. Crit. Care Med. |
pmid:8665069
|
Treille S et al. |
Kidney graft dysfunction after drug interaction between clarithromycin and cyclosporin. |
1996 |
Nephrol. Dial. Transplant. |
pmid:8672003
|
Araki J et al. |
[A case of Mounier-Kuhn syndrome]. |
1996 |
Nippon Naika Gakkai Zasshi |
pmid:8708483
|
Lowe SH et al. |
Uveitis during treatment of disseminated Mycobacterium avium-intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol. |
1996 |
Neth J Med |
pmid:8710040
|
Vasquez A et al. |
Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. The Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano Heredia and the Johns Hopkins University. |
1996 |
J. Clin. Microbiol. |
pmid:8727909
|
Craig AM et al. |
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin. |
1996 |
Pharmacoeconomics |
pmid:10160472
|
|
[Management of atypical Mycobacterium infections in AIDS-patients]. |
1996 |
Internist (Berl) |
pmid:9131082
|
Sakatani M |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (1) Continuous positive cases (failure of the initial chemotherapy)]. |
1996 |
Kekkaku |
pmid:8999139
|
Tanaka E |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial]. |
1996 |
Kekkaku |
pmid:8999140
|
Bock H and Mares A |
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia]. |
1996 |
Leber Magen Darm |
pmid:9005302
|
Tursi A et al. |
Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication. |
1996 |
Panminerva Med |
pmid:9009677
|
MacFarlane JT et al. |
Comparison of amoxycillin and clarithromycin as initial treatment of community-acquired lower respiratory tract infections. |
1996 |
Br J Gen Pract |
pmid:8983255
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Aoyama T et al. |
Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. |
1996 |
J. Pediatr. |
pmid:8917247
|
Hackelsberger A and Malfertheiner P |
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection. |
1996 |
Drug Saf |
pmid:8862962
|
Engelhardt E et al. |
[Postoperative infection with Mycobacterium chelonae]. |
1996 |
Hautarzt |
pmid:9036143
|
Kelleher P et al. |
Uveitis associated with rifabutin and macrolide therapy for Mycobacterium avium intracellulare infection in AIDS patients. |
1996 |
Genitourin Med |
pmid:9038637
|
Sjöström JE and Larsson H |
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant. |
1996 |
J. Med. Microbiol. |
pmid:8636959
|
Cammarota G et al. |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971300
|
|
Clarithromycin and omeprazole for Helicobacter pylori. |
1996 |
Med Lett Drugs Ther |
pmid:8637481
|
Pilotto A et al. |
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971305
|
Asnis DS et al. |
Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease. |
1996 |
South. Med. J. |
pmid:8638183
|
Goh KL et al. |
Helicobacter pylori eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppression therapy. |
1996 |
Eur J Gastroenterol Hepatol |
pmid:8804868
|
Berger C et al. |
Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin. |
1996 |
J. Pediatr. |
pmid:8774511
|
Sito E et al. |
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777303
|
Gabryelewicz A |
Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777307
|
Deltenre M et al. |
Strategies for Helicobacter pylori eradication in 1995: a review of international and Belgian experience. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777308
|
Roesch W |
Cost-effectiveness of H. pylori eradication. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777309
|
Nagashima R et al. |
Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. |
1996 |
Gastroenterology |
pmid:8942749
|
Ferguson PJ and Saulsbury FT |
Successful treatment of chronic Mycobacterium abscessus otitis media with clarithromycin. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8866816
|
Giacometti A et al. |
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. |
1996 |
J. Antimicrob. Chemother. |
pmid:8889715
|
|
Three new studies expand understanding of MAC therapy. |
1996 |
Am J Health Syst Pharm |
pmid:8899122
|
Tracy TS and Johns M |
Comment: delirium probably induced by clarithromycin in a patient receiving fluoxetine. |
1996 |
Ann Pharmacother |
pmid:8893135
|
Ghebremichael S et al. |
Antimycobacterial synergism of clarithromycin and rifabutin. |
1996 |
Scand. J. Infect. Dis. |
pmid:8893404
|
Yousfi MM et al. |
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8871452
|
Fisher M et al. |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. |
1996 |
Int J STD AIDS |
pmid:8876354
|
Delchier JC et al. |
Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791948
|
Jaup BH and Norrby A |
Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791950
|
Weldon MJ et al. |
A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791951
|
Tursi A et al. |
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791952
|
Pierce M et al. |
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. |
1996 |
N. Engl. J. Med. |
pmid:8663871
|
Rastogi N et al. |
In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. |
1996 |
Curr. Microbiol. |
pmid:8672093
|
Blomgren K and Alván G |
[New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified]. |
1996 |
Lakartidningen |
pmid:8656812
|
Moshkowitz M et al. |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971304
|
Laine L et al. |
Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971306
|
Naoki K et al. |
[Two cases of pulmonary disease caused by Mycobacterium chelonae subsp. abscessus]. |
1996 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:8976085
|
Iwata M et al. |
[Bronchiolitis obliterans preceding rheumatoid arthritis: effect of clarithromycin]. |
1996 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:8976086
|